MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 216 filers reported holding MEDIVATION INC in Q4 2013. The put-call ratio across all filers is 1.03 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $814,000 | -60.1% | 13,505 | -69.6% | 0.02% | -70.7% |
| Q1 2016 | $2,040,000 | +278.5% | 44,367 | +297.8% | 0.06% | +544.4% |
| Q4 2015 | $539,000 | +93.2% | 11,153 | +70.1% | 0.01% | +80.0% |
| Q3 2015 | $279,000 | -64.6% | 6,558 | -5.1% | 0.01% | -64.3% |
| Q2 2015 | $789,000 | -42.2% | 6,908 | -34.6% | 0.01% | -50.0% |
| Q1 2015 | $1,364,000 | +109.2% | 10,569 | +61.4% | 0.03% | +154.5% |
| Q4 2014 | $652,000 | +2.2% | 6,549 | -20.9% | 0.01% | +10.0% |
| Q2 2014 | $638,000 | +56.0% | 8,282 | +30.4% | 0.01% | +100.0% |
| Q1 2014 | $409,000 | +46.1% | 6,349 | +35.7% | 0.01% | +25.0% |
| Q3 2013 | $280,000 | – | 4,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |